A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035

NCT02690142 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Healthy Subjects

Interventions

DRUG: Placebo
DRUG: ABY-035 i.v.
DRUG: ABY-035 s.c.

Sponsor

Affibody

Collaborators

[object Object]